PSTV
PSTV
NASDAQ · Biotechnology

Plus Therapeutics Inc

$5.24
-0.52 (-9.03%)
As of May 16, 2:20 AM ET ·
Financial Highlights (FY 2026)
Revenue
11.52M
Net Income
-49,452,756
Gross Margin
64.4%
Profit Margin
-429.4%
Rev Growth
+187.2%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.4% 60.8% 60.8% 60.8%
Operating Margin -293.5% 3.3% 3.3% 3.5%
Profit Margin -429.4% 2.3% 3.0% 3.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.52M 35.79M 31.57M 32.41M
Gross Profit 7.41M 21.76M 19.20M 19.71M
Operating Income -33,794,354 1.17M 1.04M 1.13M
Net Income -49,452,756 827.5K 932.2K 975.1K
Gross Margin 64.4% 60.8% 60.8% 60.8%
Operating Margin -293.5% 3.3% 3.3% 3.5%
Profit Margin -429.4% 2.3% 3.0% 3.0%
Rev Growth +187.2% +6.8% +6.0% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.85M 13.26M 17.01M 14.45M
Total Equity 15.17M 21.76M 23.46M 24.58M
D/E Ratio 0.19 0.61 0.73 0.59
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -34,941,435 1.82M 1.58M 1.77M
Free Cash Flow 629.7K 483.5K 562.4K